Consensus Centene Corporation Sao Paulo

Stocks

C1NC34

BRC1NCBDR000

Managed Healthcare

Delayed Sao Paulo 05:30:31 29/10/26 am AEDT			5-day change	1st Jan Change
359.64 ^BRL	-2.44%		-2.44%	+62.01%

03/11	Goldman Sachs Adjusts Centene Price Target to $62 From $56	MT
02/11	Deutsche Bank Adjusts Centene Price Target to $87 From $85, Maintains Buy Rating	MT

9f7176df70c47179946b1167e5cf2.PMXOH6_X1fSQq6eZh6eZY9GWq6Wza6ndkOwXXifdbCk.d6yLcsSZvJrDk8jK8MXVL7P_ztzsO8CS-r9-FkCUP2pdjIVz5fqXxsre4g~739920ca932ac2feb755df06f4d1a2ba

Analysts' recommendations: Centene Corporation

03/11	Goldman Sachs Adjusts Centene Price Target to $62 From $56	MT
02/11	Deutsche Bank Adjusts Centene Price Target to $87 From $85, Maintains Buy Rating	MT
02/11	Truist Adjusts Price Target on Centene to $82 From $80, Maintains Buy Rating	MT
29/10	UBS Adjusts Price Target on Centene to $78 From $70, Maintains Neutral Rating	MT
11/09	BofA Securities Adjusts Centene Price Target to $80 From $78	MT
11/08	Argus Research Upgrades Centene to Buy From Hold, $80 Price Target	MT
04/08	JPMorgan Adjusts Price Target on Centene to $67 From $60, Maintains Neutral Rating	MT
03/08	Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating	MT
30/07	Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says	MT
30/07	UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating	MT
29/07	Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating	MT
29/07	Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating	MT
29/07	Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating	MT
29/07	Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating	MT
29/07	Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating	MT
29/07	Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating	MT
29/07	Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal…
29/07	Barclays Raises Centene Price Target to $80 From $75	MT
14/07	Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating	MT
14/07	TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating	MT
13/07	Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating	MT
13/07	Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating	MT
09/07	RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating	MT
07/07	Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60	MT
24/06	Centene's Multi-Year Recovery Underway, RBC Says	MT

More recommendations

Other Managed Healthcare

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CENTENE CORPORATION	-	-	-	-
UNITEDHEALTH GROUP INC.				+19.03%
ELEVANCE HEALTH, INC.				+16.63%
CIGNA				+15.96%
HUMANA INC.				+13.33%
CENTENE CORPORATION				+11.98%
MOLINA HEALTHCARE, INC.				+5.32%
BRADSAÚDE S.A.				+28.81%
CLOVER HEALTH INVESTMENTS, CORP.				+27.61%
PROGYNY, INC.				+17.02%
Average				+17.30%
Weighted average by Cap.				+17.40%